@article{923de693e14e406cbb5bb2129f6b9bcc,
title = "Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer",
abstract = "In “Joint EANM/SNMMI/ESTRO Practice Recommendations for the Use of 2-[18F]FDG-PET/CT External Beam Radiation Treatment Planning in Lung Cancer V1.0” clinical indications for PET-CT in (non-)small cell lung cancer are highlighted and selective nodal irradiation is discussed. Additionally, concepts about target definition, target delineation and treatment evaluation are reviewed.",
keywords = "FDG-PET/CT, Non-small cell lung cancer, Radiation treatment planning, Small cell lung cancer, Treatment response assessment",
author = "Vaz, \{Sofia C.\} and Adam, \{Judit A.\} and \{Delgado Bolton\}, \{Roberto C.\} and Pierre Vera and \{van Elmpt\}, Wouter and Ken Herrmann and Hicks, \{Rodney J.\} and Yolande Lievens and Andrea Santos and Heiko Sch{\"o}der and Bernard Dubray and Dimitris Visvikis and Troost, \{Esther G. C.\} and \{de Geus-Oei\}, Lioe-Fee",
note = "Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ken Herrmann reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, outside the submitted work. - Rodney J. Hicks is on the Scientific Advisory Board of Telix Pharmaceuticals with any honoraria donated to his institution, he is a stock holder in this company, he is also an honorary Trustee of the International Cancer Imaging Society and honorary Board Member of Neuroendocrine Cancer Australia. - All the remaining authors declare no conflict of interest. Publisher Copyright: {\textcopyright} 2022",
year = "2022",
month = mar,
day = "1",
doi = "10.1016/j.radonc.2021.12.048",
language = "English",
volume = "168",
pages = "37--39",
journal = "Radiotherapy and oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
}
